Guangzhou, China

Manman Dai

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: South China Agricultural University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manman Dai. Retrieved from https://idiyas.com/inventor/manman-dai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manman Dai: Innovator in Avian Influenza Research

Introduction

Manman Dai is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of avian influenza research. His work focuses on the development of innovative solutions to combat viral infections in poultry.

Latest Patents

Manman Dai holds a patent for the "Construction and Application of Recombinant H5N8 Subtype Avian Influenza Virus Carrying Maple Fluorescence Reporter Gene." This patent represents a crucial advancement in understanding and tracking avian influenza viruses.

Career Highlights

Dai is affiliated with South China Agricultural University, where he conducts research and develops new methodologies in virology. His work has implications for both agricultural practices and public health.

Collaborations

He has collaborated with colleagues such as Wei Song and Xiyue Chen, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Manman Dai's contributions to avian influenza research exemplify the importance of innovation in addressing global health challenges. His work continues to pave the way for advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…